SAGE Therapeutics公司(股票代码:SAGE)今日盘中股价大跌9.32%,报收于48.97美元,引发了市场的广泛关注。这一大幅下跌或与公司2024年第三季度业绩表现不佳密切相关。
SAGE Therapeutics在当日晚间公布的2024年第三季度财报显示,公司调整后每股亏损为1.53美元,而去年同期则为每股收益3.37美元。公司该季度净亏损高达9355万美元,大幅高于市场预期。虽然营收同比大增337.1%至1187万美元,但显然不足以抵消成本费用的大幅上升。
SAGE Therapeutics连续多个季度亏损数据超预期,加之今年以来其股价已下跌超60%的背景,似乎引发了市场对该公司前景增长乏力的担忧。盈利能力不及预期是导致该公司股价今日走低的主要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.